Homepage

The Analytical Service Provider

Your expert for the analysis of (bio)pharmaceuticals and ATMPs

Zentriforce Pharma Quality Promise

Scientific Expertise

At ZentriForce Pharma, project work is performed and supervised by scientists that are experienced and proficient in all aspects of their respective analytical domains, including theory and instrumentation. We work together with renowned experts in hydrodynamics, including Professor Stephen E. Harding from the NCMH Nottingham as a scientific advisor. Our dedication and involvement concerning advances in the technology and theory of our analytical services keeps us up-to-date with innovations and developments.

Cutting Edge Instrumentation

ZentriForce Pharma only uses state-of-the-art analytical equipment. We are in close contact with the manufacturers to further improve the instruments and to not miss out on new developments. Therefore, we can provide the highest possible quality service for our customers.

Full Service

We offer analytical services using superior techniques, such as analytical ultracentrifugation (AUC) or asymmetrical flow field-flow fractionation (AF4). As these techniques are complex and in need of highly qualified operators, they have not yet found application in many laboratories. We offer expert analysis on all available ZentriForce techniques and include a full-service program. We help you choose the analytical technique that is most appropriate to analyze your sample, and we assist you in understanding the resulting data. We not merely tabulate figures. We thoroughly discuss results and provide you with feedback and recommendations. You will have our full support.

ZentriForce Quality System

ZentriForce Pharma has established a laboratory quality system that closely follows the extensive and detailed guidelines provided by the WHO and the principle of “writing what you do and doing what you write”. ZentriForce implements procedural, equipment and analytical SOPs. These ensure that equipment is correctly operated and meticulously maintained by qualified personnel only, that customer samples are handled by trained laboratory operators with utmost care and precision, and that confidentiality has highest priority in all aspects of our relationship with our customers.

Data Integrity

We use templates and scripts to minimize data processing and data transfer errors. Additionally, we carry out data integrity checks to ensure the correct transfer of analyzed data to the report that we compile for you.

Training Plan

We have implemented a comprehensive training program for new employees that includes active training on our wide range of standard operation procedures (SOPs). Processes are defined and guidelines are in place to ensure uniformity, reproducibility, traceability and reliability of our work. Our SOPs cover topics that range from document control, to sample receipt and processing, to the correct handling and maintenance of calibrated or high-precision instruments. Extensive trainings and quality documents ensure that costumer samples are always handled correctly. Cautious, efficient and proficient treatment of your samples is a priority to all employees. We do our very best to reduce variability of results due to user dependence to an absolute minimum.

ZentriForce Quality System
ZentriForce Pharma has established a laboratory quality system that closely follows the extensive and detailed guidelines provided by the WHO and the principle of “writing what you do and doing what you write”. ZentriForce implements procedural, equipment and analytical SOPs. To date, close to 30 SOPs are in place.
Click here for more information
Gene Therapy
For gene therapy product development, traditional quality attributes (e.g. purity) as well as new quality attributes (e.g. the ratio of particles that carry nucleic acids to empty particles) must be addressed. The diversity of approaches for gene therapy API analysis adds a further challenge to product characterization. Our scientists have worked with a wide range of different gene therapy products, ranging from small DNA / RNA complexes over lyposome-based carrier systems and adeno-associated viruses (AAV) to viruses that are several hundred nanometers in size.
Click here for more information
Biosimilarity
Within biosimilarity studies attention is on the collection of evidence that proves that no differences (larger than method variability) in structure and purity exist between a proposed biosimilar and the reference product. Evidence is collected through extensive analytical testing. The different focus between development and biosimilarity testing require an adjusted mindset and a customized study design for the respective task. ZentriForce Pharma can be a valuable partner on your way to release a biosimilar
Click here for more information
Peptides
Despite being far less complex than full proteins, analytical handling of peptides is challenging. Species as small as peptide-based APIs require analytical instrumentation to be run at its physical limits. Expertise and extensive experience in working with such materials is imperative for successful method development. Our scientists have worked with a large number of peptide-based APIs, with sizes down to 1 kDa. They will be valuable assets where expertise and consultation in analytical method development are concerned.
Click here for more information
Previous slide
Next slide
ZentriForce Quality System
ZentriForce Pharma has established a laboratory quality system that closely follows the extensive and detailed guidelines provided by the WHO and the principle of “writing what you do and doing what you write”. ZentriForce implements procedural, equipment and analytical SOPs. To date, close to 30 SOPs are in place.
Click here for more information
Gene Therapy
For gene therapy product development, traditional quality attributes as well as new quality attributes must be addressed. Our scientists have worked with a wide range of different gene therapy products, ranging from small DNA / RNA complexes over lyposome-based carrier systems and adeno-associated viruses (AAV) to viruses that are several hundred nanometers in size.
Click here for more information
Biosimilarity
Within biosimilarity studies attention is on the collection of evidence that proves that no differences (larger than method variability) in structure and purity exist between a proposed biosimilar and the reference product. Evidence is collected through extensive analytical testing.
Click here for more information
Peptides
Despite being far less complex than full proteins, analytical handling of peptides is challenging. Species as small as peptide-based APIs require analytical instrumentation to be run at its physical limits. Expertise and extensive experience in working with such materials is imperative for successful method development. Our scientists have worked with a large number of peptide-based APIs, with sizes down to 1 kDa.
Click here for more information
Previous slide
Next slide